LINCOCIN® Principal Display Panel (lincomycin HCl)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 1-2 mL Vial Label

Pfizer

NDC 0009-0555-01

Lincocin®
lincomycin
injection, USP

300 mg/mL

1-2 mL Vial
Rx only

PRINCIPAL DISPLAY PANEL - 1-2 mL Vial Label

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton

Pfizer
NDC 0009-0555-01

Lincocin®
lincomycin
injection, USP

300 mg/mL*

For intramuscular
or intravenous use

1-2 mL Vial
Rx only

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 2 mL Vial Label 0009-0104

Pfizer
NDC 0009-0104-04

Lincocin®
lincomycin injection, USP

600 mg/2 mL
(300 mg/mL)

2 mL Multiple-Dose Vial

PRINCIPAL DISPLAY PANEL - 2 mL Vial Label 0009-0104

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton 0009-0104

Pfizer
NDC 0009-0104-04

Lincocin®
lincomycin
injection, USP

600 mg/2 mL
(300 mg/mL)*

For intramuscular
or intravenous use

Rx only

One 2 mL Multiple-Dose Vial

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton 0009-0104

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

Pfizer
NDC 0009-0107-04

Lincocin®
lincomycin injection, USP

3,000 mg/10 mL
(300 mg/mL)*

For intramuscular or
intravenous use

Rx only

10 mL Multiple-Dose Vial

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton

Pfizer
NDC 0009-0107-04

Lincocin®
lincomycin
injection, USP

3,000 mg/10 mL
(300 mg/mL)*

For intramuscular
or intravenous use

Rx only

One 10 mL Multiple-Dose Vial

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

LINCOCIN® Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

WARNING

Clostridioides difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including LINCOCIN and may range in severity from mild diarrhea to fatal colitis. Treatment with...